HOME > TOP STORIES

TOP STORIES

ORGANIZATION Vaccine Association to Standardize Presentation of Expiration Dates above Inspection Dates on Outer Packaging

March 27, 2017
BUSINESS Wholesale Dealer President Deeply Sorry for Letting Fake Harvoni into Supply Chain

March 24, 2017
TRENDS As Takeda’s R&D Rejig Progresses, Biotech JV Launch Sets Direction for Its Japan Regime

March 23, 2017
BUSINESS Japan Begins Using PD-L1 Expression Biomarker for Immune Checkpoint Inhibitors, but Challenges Linger

March 22, 2017
ORGANIZATION Study Group Presents Proposal for Future Vision for Kampo Medicines

March 21, 2017
BUSINESS Court Finds Data Manipulation, but Not False Advertising: Diovan Case

March 17, 2017
BUSINESS Novartis, Ex-Employee Found Not Guilty in Diovan Case

March 16, 2017
REGULATORY Chuikyo Begins Debate on Gap-Year Price Revisions; Industry Frets Advance Announcement of Discrepancy Threshold

March 16, 2017
BUSINESS Takeda Biotech JV to Focus on 8 Projects for Now, Eyes IPO: CEO Okumura

March 15, 2017
REGULATORY Celgene Faces Biz Improvement Order over Delays in Side Effect Reporting

March 15, 2017
BUSINESS INCJ, Takeda, Medipal to Form Biotech Venture

March 14, 2017
BUSINESS 1st Line Use, Administration Interval Will Be Key Differentiator for Keytruda: MSD Japan Chief

March 14, 2017
REGULATORY Tokyo, Osaka Govts Issue Biz Improvement Order to Dealers over Fake Harvoni

March 14, 2017
REGULATORY Reference Pricing on Agenda for CEFP Social Security Working Group

March 10, 2017
BUSINESS Pfizer’s FY2016 Japan Sales Slide 7.4% on Price Cuts, Generic Erosions

March 9, 2017
REGULATORY MHLW to Set Up Panel on Drug Distribution after Fake Harvoni Flub, Eyes GDP Ordinance

March 8, 2017
REGULATORY Tap Real-World Data for Optimal Use of High-Priced Meds: MHLW Bureau Chief

March 7, 2017
COMMENTARY Growing Hopes for Control of Hepatic Cancer; Road to Cures for Hepatitis B, NASH Might Be in Sight

March 7, 2017
INTERVIEW Chugai to Execute Area-Based Strategy Centering on General Reps: Marketing Chief

March 6, 2017
BUSINESS Bioverativ Japan Now Up and Running, Set to Keep Double-Digit Growth: President

March 3, 2017

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

MHLW Floats Deducting Private-Practice Use for Re-Pricing, but Off-Cycle Cuts Possible; GLP-1 Eyed?

Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…